Akcea Therapeutics Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Employees
-
294
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
Akcea Therapeutics General Information
Description
Akcea Therapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders. It is advancing a mature pipeline of novel drugs with the potential to treat multiple diseases. The company's drugs, volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx and AKCEA-APOCIII-LRx, are all based on antisense technology developed by Ionis Pharmaceuticals, Inc. Its most advanced drug, volanesorsen, has completed a Phase 3 clinical program for the treatment of familial chylomicronemia syndrome, or FCS, and is currently in Phase 3 clinical development for the treatment of familial partial lipodystrophy, or FPL.
Contact Information
Website
www.akceatx.comCorporate Office
- 22 Boston Wharf Road
- 9th Floor
- Boston, MA 02210
- United States
Corporate Office
- 22 Boston Wharf Road
- 9th Floor
- Boston, MA 02210
- United States
Akcea Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Akcea Therapeutics Comparisons
Industry
Financing
Details
Akcea Therapeutics Competitors (21)
One of Akcea Therapeutics’s 21 competitors is Intercept Pharmaceuticals, a Formerly VC-backed company based in Morristown, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Intercept Pharmaceuticals | Formerly VC-backed | Morristown, NJ | ||||
| Alnylam Pharmaceuticals | Formerly VC-backed | Cambridge, MA | ||||
| Gilead | Formerly VC-backed | Foster City, CA | ||||
| Cirius Therapeutics | Venture Capital-Backed | Grand Rapids, MI | ||||
| Protalix Biotherapeutics | Formerly VC-backed | Karmiel, Israel |
Akcea Therapeutics Signals
Akcea Therapeutics Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Akcea Therapeutics FAQs
-
When was Akcea Therapeutics founded?
Akcea Therapeutics was founded in 2014.
-
Where is Akcea Therapeutics headquartered?
Akcea Therapeutics is headquartered in Boston, MA.
-
What is the size of Akcea Therapeutics?
Akcea Therapeutics has 294 total employees.
-
What industry is Akcea Therapeutics in?
Akcea Therapeutics’s primary industry is Drug Discovery.
-
Is Akcea Therapeutics a private or public company?
Akcea Therapeutics is a Private company.
-
What is the current valuation of Akcea Therapeutics?
The current valuation of Akcea Therapeutics is .
-
What is Akcea Therapeutics’s current revenue?
The current revenue for Akcea Therapeutics is .
-
How much funding has Akcea Therapeutics raised over time?
Akcea Therapeutics has raised $175M.
-
Who are Akcea Therapeutics’s investors?
Novartis has invested in Akcea Therapeutics.
-
Who are Akcea Therapeutics’s competitors?
Intercept Pharmaceuticals, Alnylam Pharmaceuticals, Gilead, Cirius Therapeutics, and Protalix Biotherapeutics are some of the 21 competitors of Akcea Therapeutics.
-
When was Akcea Therapeutics acquired?
Akcea Therapeutics was acquired on 12-Oct-2020.
-
Who acquired Akcea Therapeutics?
Akcea Therapeutics was acquired by Ionis Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process